Incidence of acute myeloid leukemia after breast cancer

Caterina Giovanna Valentini, Luana Fianchi, Maria Teresa Voso, Morena Caira, Giuseppe Leone, Livio Pagano

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review


Abstract. Breast cancer is the most frequent cancer among women and the leading cause of death among middle-aged women. Early detection by mammography screening and improvement of therapeutic options have increased breast cancer sur effects of cancer treatment become increasingly important. In particular, patients treated with adjuvant chemotherapy regimens, commonly including alkylating agents and anthracyclines, are at increased risk of developing leukemia, further enhanced by the use of radiotherapy. In the last few years also the use of growth factors seems to increase the risk of secondary leukemia. The purpose of this review is to update epidemiology of therapy in breast cancer patients.
Lingua originaleEnglish
pagine (da-a)e2011069-e2011069
RivistaMediterranean Journal of Hematology and Infectious Diseases
Stato di pubblicazionePubblicato - 2011


  • breast cancer
  • therapy-related leukemia


Entra nei temi di ricerca di 'Incidence of acute myeloid leukemia after breast cancer'. Insieme formano una fingerprint unica.

Cita questo